Navigation Links
Smith & Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA
Date:7/29/2009

ST. PETERSBURG, Fla., July 29 /PRNewswire-FirstCall/ -- Smith & Nephew Inc (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announced the U.S. launch of ACTICOAT(TM) Flex 3 and ACTICOAT(TM) Flex 7, to expand the ACTICOAT portfolio. ACTICOAT Flex products have been designed to support physicians dealing with wounds and injuries at high risk of infection. Utilizing the unique Silcryst(R) nanocrystalline silver technology of ACTICOAT, the Flex line provides enhanced conformability on awkward anatomical areas such as face and hands and breakthrough stretch properties to improve patient comfort during wear. ACTICOAT Flex wound care products were recently cleared for market by the U.S. Food and Drug Administration.

Both ACTICOAT Flex 3 and ACTICOAT Flex 7 were cleared for use by Health Canada in late 2008. Dr. Sarvesh Logsetty, MD, FRCSC, FACS, Director of Manitoba Firefighters Burn Unit and Associate Professor, Plastic & General Surgery at the University of Manitoba commented on the product's excellent performance characteristics. "ACTICOAT Flex is a natural addition to the brand of dressings I trust when treating patients with wounds highly susceptible to infection. These dressings are preferable when treating wounds in areas of the body that require a high level of conformability, and when it is important to minimize trauma to the wound when removing the dressing," stated Dr. Logsetty. "The Flex dressing allows exudate to pass through, which is a great advantage," he explained.

"Combining the flexibility of the polyester mesh substrate with the proven effectiveness of ACTICOAT's nanocrystalline silver technology is an exciting and significant development for the ACTICOAT brand. The ACTICOAT Flex range of dressings is the result of listening to health care providers and understanding their needs when dealing with wounds in hard to dress areas, especially when risk of infection is high. The feedback from Canadian practitioners has been overwhelmingly positive, allowing them to successfully manage complex soft tissue injuries," said Tom Dugan, President of North America Wound Management.

"We are delighted with ACTICOAT Flex wound products. It represents our commitment to the supply of credible solutions to address clinicians' ongoing concerns," commented Roger Teasdale, President of Smith & Nephew Wound Management. "This product introduction is key to our focus on Infection Management, which along with Exudate Management and Negative Pressure Wound Therapy, comprise our three focused elements of the Wound Management strategy."

For more information regarding Smith & Nephew, please visit our Web site at http://www.smith-nephew.com

(TM) Trademark of Smith & Nephew

(R) Trademark of Nucryst Pharmaceuticals

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were nearly $3.8 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.

Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.


'/>"/>
SOURCE Smith & Nephew
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hilary Smith Upped to Senior Vice President, Communications, NBC Universal Women & Lifestyle Entertainment Networks
2. UK Court of Appeal Rules in Smith & Nephews Favour
3. Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels
4. Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline
5. H. D. Smith Promotes Leadership to Fill Two Senior Roles
6. GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare
7. GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
8. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
9. Smiths Donates $837,000 to Primary Childrens Medical Center in Utah
10. H. D. Smith Appoints Dave Watkins Chief Financial Officer
11. Leading Alzheimers Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: